India Ophthalmic Clinical Trials Market To Reach $61.01 Million By 2030

India Ophthalmic Clinical Trials Market Growth & Trends

The India ophthalmic clinical trials market size is expected to reach USD 61.01 million by 2030, growing at a CAGR of 6.58% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to factors such as the increasing prevalence of eye disorders, favorable regulatory environment, increasing investments in healthcare infrastructure, and availability of skilled workforce.

An increase in technological advancements and investment of multinational companies in the country serve as ideal opportunities for the growth of the market. Telemedicine technologies have enabled remote consultations and monitoring of patients participating in clinical trials. Remote monitoring devices such as smartphones, wearable sensors, and home monitoring systems allow researchers to collect real-time data on patients' eye health and treatment outcomes. These advancements have improved patient recruitment & retention and have reduced the burden of frequent clinic visits.

Furthermore, the increasing prevalence of eye conditions such as macular degeneration, diabetic retinopathy, and glaucoma are key drivers for the ophthalmic clinical trials industry’s growth. As the population ages in the country and the incidence of these conditions rises, there is a growing demand for effective treatments and therapies. Furthermore, advancements in genetic research and personalized medicine are expected to drive innovation in this field, leading to more specialized and efficient treatments for eye diseases. These factors collectively contribute to the market growth in the coming years. 

 Request a free sample copy or view report summary: India Ophthalmic Clinical Trials Market Report

India Ophthalmic Clinical Trials Market Report Highlights

• Based on product, the drugs/pharmaceuticals segment captured the highest market share in 2022.The growing prevalence of eye disorders and the increasing demand for effective treatment options have propelled the segment’s growth

• Based on indication, the retinopathy segment dominated the market in 2022 owing to the increasing incidence of diabetes in the country

• Based on phase, the clinical phase segment dominated the market in 2022. The involvement of pharmaceutical companies, research organizations, and healthcare institutions in different phases of clinical trials is contributing to the growth

• Based on service type, the clinical trial data management services segment dominated the market in 2022 as it enhances the efficiency, accuracy, and compliance of ophthalmic clinical trials in the country

• Based on sponsor type, the pharmaceutical/biopharmaceutical companies dominated the market in 2022, as these companies invest significant resources in research and development (R&D) activities focused on ophthalmic treatments and interventions 

India Ophthalmic Clinical Trials Market Segmentation

Grand View Research has segmented the India ophthalmic clinical trials market based on product, indication, phase, service type, and sponsor type:

India Ophthalmic Clinical Trials Product Outlook (Revenue, USD Million, 2018 - 2030)

• Devices

  • Surgical Devices

    • Intraocular Lenses

      • Aspheric IOLs

      • Toric IOLs

      • Multifocal IOLs

      • Monofocal IOLs

      • Others

    • Others (Ophthalmic Lasers and other surgical devices)

  • Diagnostic Devices

• Drugs/Pharmaceuticals

  • OTC Drugs

  • Prescription Drugs

India Ophthalmic Clinical Trials Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Macular Degeneration

• Glaucoma

• Dry Eye Disease

• Retinopathy

• Uveitis

• Macular Edema

• Blepharitis

• Cataract

• Optic Neuropathy

• Others

India Ophthalmic Clinical Trials Phase Outlook (Revenue, USD Million, 2018 - 2030)

• Discovery Phase

• Preclinical Phase

• Clinical Phase

  • Phase I

  • Phase II

  • Phase III

  • Phase IV

India Ophthalmic Clinical Trials Service Type Outlook (Revenue, USD Million, 2018 - 2030)

• Protocol Designing

• Site Identification

• Patient Recruitment

• Laboratory Services

• Bioanalytical Testing Services

• Clinical Trial Data Management Services

• Others

India Ophthalmic Clinical Trials Sponsor Type Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical/Biopharmaceutical Companies

• Medical Device Companies

• Others

List of Key Players in India Ophthalmic Clinical Trials Market

• ProRelix Services LLP

• Abiogenesis Clinpharm Pvt Ltd.

• Veeda Clinical Research

• Catawba Research, LLC

• Novotech

• Catalyst Clinical Services Pvt. Ltd.

• Navitas Life Sciences

• Vedic Lifesciences Pvt Ltd.

• Vimta Labs Ltd

• Others